An international comparative analysis and roadmap to sustainable biosimilar markets.

Alnaqbi KA, Bellanger A, Brill A, Castañeda-Hernández G, Clopés Estela A, Delgado Sánchez O, García-Alfonso P, Gyger P, Heinrich D, Hezard G, Kakehasi A, Koehn C, Mariotte O, Mennini F, Mayra Pérez-Tapia S, Pistollato M, Saada R, Sasaki T, Tambassis G, Thill M, Werutsky G, Wilsdon T, Simoens S

Open source

DOI: 10.3389/fphar.2023.1188368
Published: 2023
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2023.1188368,
  title = {An international comparative analysis and roadmap to sustainable biosimilar markets.},
  author = {Alnaqbi KA and Bellanger A and Brill A and Castañeda-Hernández G and Clopés Estela A and Delgado Sánchez O and García-Alfonso P and Gyger P and Heinrich D and Hezard G and Kakehasi A and Koehn C and Mariotte O and Mennini F and Mayra Pérez-Tapia S and Pistollato M and Saada R and Sasaki T and Tambassis G and Thill M and Werutsky G and Wilsdon T and Simoens S},
  year = {2023},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2023.1188368},
  url = {https://doi.org/10.3389/fphar.2023.1188368}
}

RIS

TY  - JOUR
TI  - An international comparative analysis and roadmap to sustainable biosimilar markets.
AU  - Alnaqbi KA
AU  - Bellanger A
AU  - Brill A
AU  - Castañeda-Hernández G
AU  - Clopés Estela A
AU  - Delgado Sánchez O
AU  - García-Alfonso P
AU  - Gyger P
AU  - Heinrich D
AU  - Hezard G
AU  - Kakehasi A
AU  - Koehn C
AU  - Mariotte O
AU  - Mennini F
AU  - Mayra Pérez-Tapia S
AU  - Pistollato M
AU  - Saada R
AU  - Sasaki T
AU  - Tambassis G
AU  - Thill M
AU  - Werutsky G
AU  - Wilsdon T
AU  - Simoens S
PY  - 2023
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2023.1188368
UR  - https://doi.org/10.3389/fphar.2023.1188368
ER  -

APA

KA, A., A, B., A, B., G, C., A, C. E., O, D. S., P, G., P, G., D, H., G, H., A, K., C, K., O, M., F, M., S, M. P., M, P., R, S., T, S., G, T., M, T., G, W., T, W., & S, S. (2023). An international comparative analysis and roadmap to sustainable biosimilar markets.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2023.1188368

Source records

pubmed · retrieved 2026-09-26T01:03:50.654Z